Literature DB >> 20582702

Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis.

Marijke C Jansen-van der Weide1, Marcel J W Greuter, Liesbeth Jansen, Jan C Oosterwijk, Ruud M Pijnappel, Geertruida H de Bock.   

Abstract

BACKGROUND: Women with familial or genetic aggregation of breast cancer are offered screening outside the population screening programme. However, the possible benefit of mammography screening could be reduced due to the risk of radiation-induced tumours. A systematic search was conducted addressing the question of how low-dose radiation exposure affects breast cancer risk among high-risk women.
METHODS: A systematic search was conducted for articles addressing breast cancer, mammography screening, radiation and high-risk women. Effects of low-dose radiation on breast cancer risk were presented in terms of pooled odds ratios (OR).
RESULTS: Of 127 articles found, 7 were selected for the meta-analysis. Pooled OR revealed an increased risk of breast cancer among high-risk women due to low-dose radiation exposure (OR = 1.3, 95% CI: 0.9- 1.8). Exposure before age 20 (OR = 2.0, 95% CI: 1.3-3.1) or a mean of ≥5 exposures (OR = 1.8, 95% CI: 1.1-3.0) was significantly associated with a higher radiation-induced breast cancer risk.
CONCLUSION: Low-dose radiation increases breast cancer risk among high-risk women. When using low-dose radiation among high-risk women, a careful approach is needed, by means of reducing repeated exposure, avoidance of exposure at a younger age and using non-ionising screening techniques.

Entities:  

Mesh:

Year:  2010        PMID: 20582702     DOI: 10.1007/s00330-010-1839-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  51 in total

1.  A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

Authors:  Pia Vahteristo; Jirina Bartkova; Hannaleena Eerola; Kirsi Syrjäkoski; Salla Ojala; Outi Kilpivaara; Anitta Tamminen; Juha Kononen; Kristiina Aittomäki; Päivi Heikkilä; Kaija Holli; Carl Blomqvist; Jiri Bartek; Olli-P Kallioniemi; Heli Nevanlinna
Journal:  Am J Hum Genet       Date:  2002-07-28       Impact factor: 11.025

2.  Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.

Authors:  Deborah Goldfrank; Shannon Chuai; Jonine L Bernstein; Teresa Ramon Y Cajal; Johanna B Lee; M Carmen Alonso; Orland Diez; Monserrat Baiget; Noah D Kauff; Kenneth Offit; Mark Robson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

3.  Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.

Authors:  Steven A Narod; Jan Lubinski; Parviz Ghadirian; Henry T Lynch; Pal Moller; William D Foulkes; Barry Rosen; Charmaine Kim-Sing; Claudine Isaacs; Susan Domchek; Susan Domcheck; Ping Sun
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Cancers detected and induced, and associated risk and benefit, in a breast screening programme.

Authors:  J Law; K Faulkner
Journal:  Br J Radiol       Date:  2001-12       Impact factor: 3.039

Review 6.  Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.

Authors:  Ellen Warner; Hans Messersmith; Petrina Causer; Andrea Eisen; Rene Shumak; Donald Plewes
Journal:  Ann Intern Med       Date:  2008-05-06       Impact factor: 25.391

7.  Low-dose medical radiation exposure and breast cancer risk in women under age 50 years overall and by estrogen and progesterone receptor status: results from a case-control and a case-case comparison.

Authors:  Huiyan Ma; Colin K Hill; Leslie Bernstein; Giske Ursin
Journal:  Breast Cancer Res Treat       Date:  2007-07-07       Impact factor: 4.872

8.  Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. II. A Mendelian single-locus model of cancer predisposition and radiosensitivity for predicting cancer risks in populations.

Authors:  R Chakraborty; K Sankaranarayanan
Journal:  Radiat Res       Date:  1995-09       Impact factor: 2.841

Review 9.  Radiation and breast cancer: a review of current evidence.

Authors:  Cécile M Ronckers; Christine A Erdmann; Charles E Land
Journal:  Breast Cancer Res       Date:  2004-11-23       Impact factor: 6.466

10.  Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.

Authors:  Annegien Broeks; Linde M Braaf; Angelina Huseinovic; Anke Nooijen; Jos Urbanus; Frans B L Hogervorst; Marjanka K Schmidt; Jan G M Klijn; Nicola S Russell; Flora E Van Leeuwen; Laura J Van 't Veer
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  18 in total

1.  Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.

Authors:  Kathryn P Lowry; Janie M Lee; Chung Y Kong; Pamela M McMahon; Michael E Gilmore; Jessica E Cott Chubiz; Etta D Pisano; Constantine Gatsonis; Paula D Ryan; Elissa M Ozanne; G Scott Gazelle
Journal:  Cancer       Date:  2011-09-20       Impact factor: 6.860

Review 2.  State of the evidence 2017: an update on the connection between breast cancer and the environment.

Authors:  Janet M Gray; Sharima Rasanayagam; Connie Engel; Jeanne Rizzo
Journal:  Environ Health       Date:  2017-09-02       Impact factor: 5.984

Review 3.  Intensified surveillance for early detection of breast cancer in high-risk patients.

Authors:  Ulrich Bick
Journal:  Breast Care (Basel)       Date:  2015-02       Impact factor: 2.860

4.  Disparities in the Context of Opportunities for Cancer Prevention in Early Life.

Authors:  Greta M Massetti; Cheryll C Thomas; Kathleen R Ragan
Journal:  Pediatrics       Date:  2016-11       Impact factor: 7.124

5.  Opportunities During Early Life for Cancer Prevention: Highlights From a Series of Virtual Meetings With Experts.

Authors:  Dawn M Holman; Natasha D Buchanan
Journal:  Pediatrics       Date:  2016-11       Impact factor: 7.124

6.  Is quality and completeness of reporting of systematic reviews and meta-analyses published in high impact radiology journals associated with citation rates?

Authors:  Christian B van der Pol; Matthew D F McInnes; William Petrcich; Adam S Tunis; Ramez Hanna
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

7.  Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.

Authors:  Xuan-Anh Phi; Sepideh Saadatmand; Geertruida H De Bock; Ellen Warner; Francesco Sardanelli; Martin O Leach; Christopher C Riedl; Isabelle Trop; Maartje J Hooning; Rodica Mandel; Filippo Santoro; Gek Kwan-Lim; Thomas H Helbich; Madeleine M A Tilanus-Linthorst; Edwin R van den Heuvel; Nehmat Houssami
Journal:  Br J Cancer       Date:  2016-02-23       Impact factor: 7.640

8.  Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness.

Authors:  G H de Bock; K M Vermeulen; L Jansen; J C Oosterwijk; S Siesling; M D Dorrius; T Feenstra; N Houssami; M J W Greuter
Journal:  Br J Cancer       Date:  2013-04-11       Impact factor: 7.640

9.  Rapid point-of-care breath test for biomarkers of breast cancer and abnormal mammograms.

Authors:  Michael Phillips; J David Beatty; Renee N Cataneo; Jan Huston; Peter D Kaplan; Roy I Lalisang; Philippe Lambin; Marc B I Lobbes; Mayur Mundada; Nadine Pappas; Urvish Patel
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  No strong evidence for increased risk of breast cancer 8-26 years after multiple mammograms in their 30s in females at moderate and high familial risk.

Authors:  D Gareth Evans; C John Kotre; Elaine Harkness; Mary Wilson; Anthony J Maxwell; Anthony Howell
Journal:  Br J Radiol       Date:  2016-01-21       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.